Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China
- 67 Downloads
To explore the prevalence and ethnic differences of osteosarcopenic obesity (OSO) and dyslipidemia and their relationship among Maonan, Mulam, Hmong, and Yao minorities in China.
A total of 2315 Maonan, Mulam, Hmong, and Yao women aged 20–95 from Guangxi were included in this study. Questionnaire survey was carried out and their blood lipids were tested. Body compositions were measured by bioelectrical impedance analysis, and T-score was assessed by ultrasonic examination, respectively.
Our study showed ethnic-specific prevalence of OSO. In older women, the incidence rates of OSO in Mulam were 4.9, 12.6, and 11.5% in Maonan, Mulam, and Hmong ethnicity, respectively. In younger group, the incidence rates of OSO were 0.4, 0.4, and 0.6%, respectively. However, there is no prevalence of OSO in Yao women in two groups. The prevalence of dyslipidemia in younger women was 22.86, 29.89, 43.35, and 80.00% in group numbering one, two, and three, respectively. In older women, it was 29.13, 39.02, 41.37, and 52.38%, respectively. Based on logistic regression analysis, after controlling for covariates, dyslipidemia in younger group was positively associated with a higher number of adverse body composition, especially for OSO (OR = 12.53, 95%CI 1.34–116.99). Compared with normal women, OSO women in older group were also more likely to have dyslipidemia (OR = 6.75, 95%CI 3.19–14.31).
OSO may be a risk factor for dyslipidemia in the ethnic groups. Thus, efforts to promote healthy aging should be focused on preventing obesity and maintaining bone health and muscle mass.
KeywordsOsteosarcopenic obesity Dyslipidemia Ethnic differences
We thank the participants and relevant research staff for their contributions to the survey.
This work was supported by grants from the National Science Foundation of China (No. 31160222).
Compliance with ethical standards
Written informed consent was obtained from all participants in this cross-sectional study, which has been supported by the National Natural Science Foundation of China and given approval by the Institution Review Board for studies using human subjects. Ethical approval was given by the medical ethics committee of Guangxi Medical University.
Conflicts of interest
- 3.Tao Y, Yu J, Tao Y, Pang H, Yu Y, Yu Y, Jin L (2016) Comparison of the combined obesity indices to predict cardiovascular diseases risk factors and metabolic syndrome in Northeast China. Int J Environ Res Public Health 13:801Google Scholar
- 9.Du R (2004) Population genetics in China. Science Press, BeijingGoogle Scholar
- 12.guide jcoCadp (2007) Chinese adult dyslipidemia prevention guide. Journal of Chinese Cardiology 35:390–419Google Scholar
- 14.Dufour AB, Hannan MT, Murabito JM, Kiel DP, McLean RR (2013) Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. The journals of gerontology Series A, Biological sciences and medical. sciences 68:168–174Google Scholar
- 27.Baek SJ, Nam GE, Han KD, Choi SW, Jung SW, Bok AR, Kim YH, Lee KS, Han BD, Kim DH (2014) Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Investig 37:247–260CrossRefGoogle Scholar